Search

Your search keyword '"Detti, B"' showing total 374 results

Search Constraints

Start Over You searched for: Author "Detti, B" Remove constraint Author: "Detti, B"
374 results on '"Detti, B"'

Search Results

1. Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis

6. PSICHE trial (NCT05022914): PSMA guided approach for bIochemical relapse after prostatectomy- a prospective trial

11. Stereotactic body radiation therapy and abiraterone acetate for patients affected by oligometastatic castrate-resistant prostate cancer: Freedom from biochemical, radiological progression free survival and freedom from following treatment approaches within a randomized phase II trial (ARTO – NCT03449719)

13. Clinical Outcomes and Dosimetric Predictive Factors in Patients Undergoing Reirradiation for Recurrent Meningiomas

16. PD-0576 Stereotactic reirradiation for locally recurrent prostate cancer after definitive radiotherapy

18. PD-0652 Re-irradiation of recurrent intracranial meningiomas: an Italian multicenter retrospective study

19. PO-1354 Pattern of failure after stereotactic body radiotherapy to liver metastases: impact of local control

20. PO-1459 Stereotactic salvage radiotherapy for prostate red relapse, early analysis from a prospective trial

23. How has prostate cancer radiotherapy changed in Italy between 2004 and 2011? An analysis of the national patterns-of-practice (pop) database by the uro-oncology study group of the italian society of radiotherapy and clinical oncology (airo)

24. How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study

26. PO-1363 Detection rate of 68Ga-PSMA PET/CT from a prospective study: PSICHE trial (NCT05022914)

27. OC-0605 Early outcomes of a randomized trial of SBRT and Abiraterore in mCPRC: ARTO trial NCT03449719

28. PO-1299 Charlson Comorbidity Index for patients selection in definitive chemoradiation for anal carcinoma

29. PD-0411 Predictive factors of late GU toxicity after Cyberknife re-irradiation for locally recurrent PCa

30. OC-0935 Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis

32. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)

34. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

37. Concomitant immuno-radiotherapy in metastatic renal cell carcinoma: multicenter analysis

38. Dose-Escalated Accelerated Hypofractionation for Patients With a Newly Diagnosed Glioblastoma: A Pooled International Study

39. Impact of Gastrointestinal Side Effects on Patients’ Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study

41. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

42. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)

43. PO-1316 Stereotactic radiotherapy in recurrent prostate cancer after postoperative or definitive irradiation

44. PO-1366 Pattern of recurrence after SBRT in prostate cancer patients with nodal pelvic relapse

45. PO-1393 ARTO (NCT03449719), quality of life monocentric report after stereotactic treatment and abiraterone

46. PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach

47. PO-1347 Prostate cancer RT pattern of practice in Italy between 2004-2011: an analysis by the AIRO database

49. P104 - Stereotactic body radiation therapy and abiraterone acetate for patients affected by oligometastatic castrate-resistant prostate cancer: Freedom from biochemical, radiological progression free survival and freedom from following treatment approaches within a randomized phase II trial (ARTO – NCT03449719)

Catalog

Books, media, physical & digital resources